vs

Side-by-side financial comparison of Black Rock Coffee Bar, Inc. (BRCB) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Black Rock Coffee Bar, Inc. is the larger business by last-quarter revenue ($51.5M vs $37.2M, roughly 1.4× Organogenesis Holdings Inc.).

Black Rock Coffee Bar, Inc. is a U.S.-based specialty coffee retail chain that offers handcrafted premium coffee beverages, energy drinks, baked goods, and light snacks. It operates in-store and drive-thru locations primarily across western U.S. states, prioritizing high-quality customizable products and community-focused consumer experiences.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

BRCB vs ORGO — Head-to-Head

Bigger by revenue
BRCB
BRCB
1.4× larger
BRCB
$51.5M
$37.2M
ORGO

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BRCB
BRCB
ORGO
ORGO
Revenue
$51.5M
$37.2M
Net Profit
$-712.0K
Gross Margin
30.8%
Operating Margin
-12.4%
-185.1%
Net Margin
-1.4%
Revenue YoY
-57.1%
Net Profit YoY
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRCB
BRCB
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$225.6M
Q3 25
$51.5M
$150.9M
Q2 25
$101.0M
Q1 25
$86.7M
Q4 24
$126.7M
Q3 24
$115.2M
Q2 24
$130.2M
Net Profit
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
$43.7M
Q3 25
$-712.0K
$21.6M
Q2 25
$-9.4M
Q1 25
$-18.8M
Q4 24
$7.7M
Q3 24
$12.3M
Q2 24
$-17.0M
Gross Margin
BRCB
BRCB
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
BRCB
BRCB
ORGO
ORGO
Q1 26
-185.1%
Q4 25
28.1%
Q3 25
-12.4%
13.7%
Q2 25
-12.5%
Q1 25
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-10.7%
Net Margin
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
19.4%
Q3 25
-1.4%
14.3%
Q2 25
-9.3%
Q1 25
-21.7%
Q4 24
6.1%
Q3 24
10.7%
Q2 24
-13.1%
EPS (diluted)
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
$0.31
Q3 25
$-0.05
$0.11
Q2 25
$-0.10
Q1 25
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRCB
BRCB
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$32.6M
$91.4M
Total DebtLower is stronger
$20.0M
Stockholders' EquityBook value
$43.0M
Total Assets
$323.2M
$520.0M
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRCB
BRCB
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$32.6M
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
Q3 25
$20.0M
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
$300.1M
Q3 25
$43.0M
$255.1M
Q2 25
$233.2M
Q1 25
$242.9M
Q4 24
$262.9M
Q3 24
$278.5M
Q2 24
$263.5M
Total Assets
BRCB
BRCB
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$598.7M
Q3 25
$323.2M
$509.8M
Q2 25
$461.1M
Q1 25
$467.4M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$443.2M
Debt / Equity
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
Q3 25
0.46×
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRCB
BRCB
ORGO
ORGO
Operating Cash FlowLast quarter
$-2.9M
Free Cash FlowOCF − Capex
$-25.8M
FCF MarginFCF / Revenue
-50.2%
Capex IntensityCapex / Revenue
44.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
$39.4M
Q3 25
$-2.9M
$3.1M
Q2 25
$-32.9M
Q1 25
$-19.9M
Q4 24
$10.9M
Q3 24
$8.7M
Q2 24
$4.7M
Free Cash Flow
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$-25.8M
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
-50.2%
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
44.5%
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
BRCB
BRCB
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons